Researchers have developed a novel ecological index, the Ecological Network Balance Index (ENBI), capable of measuring gut health. This index distinguishes healthy microbiomes from dysbiosis and correlates with disease progression across multiple gastrointestinal and systemic conditions.
The ENBI quantifies shifts in microbial interactions, moving beyond traditional diversity metrics. Diseased microbiomes consistently show higher ENBI values compared to healthy samples, robustly differentiating health and disease across inflammatory bowel disease, irritable bowel syndrome, Clostridioides difficile infection, and colorectal cancer. ENBI values also correlate with disease stage, indicating progressive increases in positive microbial interactions as pathology advances.
This finding positions ENBI as a potential biomarker for gut health monitoring and disease progression. If validated, it could enable earlier dysbiosis detection, guide personalized interventions, and monitor treatment response, advancing precision strategies for gut health.